|
|
 |
|
Viewing report
|
|
|
|
Drugs for the Diseases of Aging
Fuji-Keizai USA, Inc, Oct 2011, Pages: 263
US Markets and Trends for Prescription Medicines Used Predominantly by Persons Age 50 and older
This report reviews, analyzes and sizes the markets for prescription medicines used to address diseases and conditions that predominantly affect persons age 50 and older. It focuses on the large U.S. market, with five-year revenue projections to 2015. It also presents merger and acquisition activity, research and development (R&D) initiatives and venture capital activity for current and emerging drug developers.
Specific market segments examined include:
- Alzheimer’s disease
- Arthritis
- Cancer
- Cardiovascular disease
- Diabetes
- Erectile dysfunction
- Eye disease
- Hair loss
- High cholesterol
- Hypertension
- Kidney disease
- Osteoporosis
- Parkinson’s disease
- Stroke
- Wrinkles
In 2010, sales of these drugs used by exclusively persons age 50 and older were $50 billion. Through 2015, sales will expand by 5.3% per year to reach more than $64 billion.
On a segment by segment basis, medicines used for wrinkle reduction will exhibit the greatest growth at 17.7% per year, followed by drugs used to address Alzheimer’s disease at 12.1% per year.
Historical information for this report was gathered from a wide variety of published sources including company reports and filings, government documents, legal filings, trade journals, newspapers and business press, analysts’ reports and other sources. Interviews with company representatives and other experts were conducted to capture the perspectives from industry participants’ point of view and assess trends, and form the basis of the forecasting and competitive analysis.
More than 200 detailed tables and figures provide key data about revenues and market size, market share and segments. Internet links help readers access companies' own web sites for further review.
|
|
|
|
